These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37452163)

  • 1. Potential metabolic biomarkers of critical limb ischemia in people with type 2 diabetes mellitus.
    Safari-Alighiarloo N; Mani-Varnosfaderani A; Madani NH; Tabatabaei SM; Babaei MR; Khamseh ME
    Metabolomics; 2023 Jul; 19(7):66. PubMed ID: 37452163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Muscle Bioenergetics in Critical Limb Ischemia and Diabetes.
    Rontoyanni VG; Blears E; Nunez Lopez O; Ogunbileje J; Moro T; Bhattarai N; Randolph AC; Fry CS; Fankhauser GT; Cheema ZF; Murton AJ; Volpi E; Rasmussen BB; Porter C
    J Surg Res; 2023 Aug; 288():108-117. PubMed ID: 36963297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.
    Vallabhaneni R; Kalbaugh CA; Kouri A; Farber MA; Marston WA
    J Vasc Surg; 2016 Jan; 63(1):105-12. PubMed ID: 26412436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia.
    Singh GD; Armstrong EJ; Waldo SW; Alvandi B; Brinza E; Hildebrand J; Amsterdam EA; Humphries MD; Laird JR
    Vasc Med; 2017 Jun; 22(3):210-217. PubMed ID: 28466753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials.
    Spreen MI; Gremmels H; Teraa M; Sprengers RW; Verhaar MC; Statius van Eps RG; de Vries JP; Mali WP; van Overhagen H;
    Diabetes Care; 2016 Nov; 39(11):2058-2064. PubMed ID: 27612499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
    Sen I; Agarwal S; Tharyan P; Forster R
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early ABI Testing May Decrease Risk of Amputation for Patients With Lower Extremity Ulcers.
    Aguirre A; Sharma K; Arora A; Humphries MD
    Ann Vasc Surg; 2022 Feb; 79():65-71. PubMed ID: 34656726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in brain natriuretic peptide and other factors between Japanese peripheral arterial disease patients with critical limb ischemia and intermittent claudication.
    Kumakura H; Kanai H; Araki Y; Hojo Y; Kasama S; Sumino H; Iwasaki T; Takayama Y; Ichikawa S; Fujita K; Nakashima K; Minami K
    J Atheroscler Thromb; 2013; 20(11):798-806. PubMed ID: 23831586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falsely high ankle-brachial index predicts major amputation in critical limb ischemia.
    Silvestro A; Diehm N; Savolainen H; Do DD; Vögelea J; Mahler F; Zwicky S; Baumgartner I
    Vasc Med; 2006 May; 11(2):69-74. PubMed ID: 16886836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.
    Li JY; Yang XY; Wang XF; Jia X; Wang ZJ; Deng AP; Bai XL; Zhu L; Li BH; Feng ZB; Li Y; Wang L; Jin S
    Sci Rep; 2017 Sep; 7(1):11272. PubMed ID: 28900239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-323b-5p acts as a novel diagnostic biomarker for critical limb ischemia in type 2 diabetic patients.
    Cheng B; Li JY; Li XC; Wang XF; Wang ZJ; Liu J; Deng AP
    Sci Rep; 2018 Oct; 8(1):15080. PubMed ID: 30305681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia.
    Castronuovo JJ; Adera HM; Smiell JM; Price RM
    J Vasc Surg; 1997 Oct; 26(4):629-37. PubMed ID: 9357464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the relationship between ankle-brachial and toe-brachial indices and infragenicular arterial patency in critical limb ischemia.
    Bunte MC; Jacob J; Nudelman B; Shishehbor MH
    Vasc Med; 2015 Feb; 20(1):23-9. PubMed ID: 25630991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of perioperative changes in ankle-brachial index with regard to extremity-related outcome in non-diabetic patients with critical limb ischemia.
    Bischoff MS; Meisenbacher K; Peters AS; Weber D; Bisdas T; Torsello G; Böckler D;
    Langenbecks Arch Surg; 2018 Sep; 403(6):741-748. PubMed ID: 29911291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation in a Chronic Limb Threatening Ischemia Randomized Trial Is Inversely Correlated With Regional Amputation Rate in Limb Threatening Ischemia Patients.
    Siracuse JJ; Goodney PP; Menard MT; Rosenfield K; Van Over M; Hamza TH; Eid M; Villarreal MF; Strong MB; Farber A
    Ann Surg; 2021 Oct; 274(4):621-626. PubMed ID: 34506317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease.
    Krishnamurthy V; Munir K; Rectenwald JE; Mansour A; Hans S; Eliason JL; Escobar GA; Gallagher KA; Grossman PM; Gurm HS; Share DA; Henke PK
    Vasc Med; 2014 Dec; 19(6):491-9. PubMed ID: 25292418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
    Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M;
    Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: Possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway.
    Khaled S; Abdelaziz RR; Suddek GM; Elshaer SL
    Int Immunopharmacol; 2023 Mar; 116():109817. PubMed ID: 36773570
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.